Correlation Between Radcom and Molecular Partners

Can any of the company-specific risk be diversified away by investing in both Radcom and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Radcom and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Radcom and Molecular Partners AG, you can compare the effects of market volatilities on Radcom and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Radcom with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Radcom and Molecular Partners.

Diversification Opportunities for Radcom and Molecular Partners

0.05

Correlation Coefficient

Radcom  Molecular Partners

Significant diversification

The 3 months correlation between Radcom and Molecular is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Radcom and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Radcom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Radcom are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Radcom i.e., Radcom and Molecular Partners go up and down completely randomly.

Pair Corralation between Radcom and Molecular Partners

Given the investment horizon of 90 days Radcom is expected to generate 0.75 times more return on investment than Molecular Partners. However, Radcom is 1.33 times less risky than Molecular Partners. It trades about 0.0 of its potential returns per unit of risk. Molecular Partners AG is currently generating about -0.03 per unit of risk. If you would invest  1,312  in Radcom on May 17, 2025 and sell it today you would lose (32.00) from holding Radcom or give up 2.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Radcom  vs.  Molecular Partners AG

Radcom

Risk-Adjusted Performance

Weakest

Over the last 90 days Radcom has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Radcom is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Molecular Partners

Risk-Adjusted Performance

Weakest

Over the last 90 days Molecular Partners AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's essential indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Radcom and Molecular Partners

The main advantage of trading using opposite Radcom and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Radcom position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.

The idea behind Radcom and Molecular Partners AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.